Axelyf: Funding, Investors & Team (Nov 2026)
Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
Axelyf has raised $1.8M across 1 funding round on record, the most recent a Seed of $1.8M announced in Oct 2026.
That round is below the $7.8M median round size for United States companies tracked on FundedIQ over the last two years.
Axelyf Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Axelyf Funding Rounds
Axelyf Investors
Axelyf Founders and Leadership Team
Contact details for the Axelyf team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Axelyf Funding in Context
Axelyf's latest round of $1.8M is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Axelyf in Biotechnology and Brookline
Companies Similar to Axelyf
Oyster Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
General Translation is a SaaS company that offers language translation services.
Nebuly analyzes each LLM interaction, monitors user behaviour and highlights crucial user insights.
Agentcard lets AI agents pay with their users' own cards, approved by the user.
Duet is a healthcare provider that connects the healthcare with nurse practitioners to help the patients.
Vera Money is an AI money app that helps Gen Z and Millennials spend, save, and plan with less stress.
AI-native pricing management
LangChain is a language model application development library that develops a language model framework to…
Mirendil is an artificial intelligence research company that develops systems designed to automate and…
Luminal provides a machine learning compiler and serverless cloud platform that automates PyTorch model…
Hatz AI enables Managed Service Providers (MSPs) to establish a business focused on offering AI services,…
Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…
Axelyf Funding FAQs
What does Axelyf do?
Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
How much funding has Axelyf raised?
Axelyf has raised $1.8M across 1 round on record. The most recent is a Seed of $1.8M announced in Oct 2026.
When did Axelyf last raise funding?
Axelyf's most recent funding round on record is a Seed of $1.8M, announced in Oct 2026.
Who has invested in Axelyf?
Investors on record for Axelyf include Brunnur Ventures, Omega ehf, Silfurberg.
Who founded Axelyf?
FundedIQ lists Brynja Einarsdottir (Co-Founder), Orn Almarsson (Co-Founder) at Axelyf.
Where is Axelyf headquartered?
Axelyf is based in Brookline, United States.
How many employees does Axelyf have?
Axelyf is in the 1-10 employee band.
When was Axelyf founded?
Axelyf was founded in 2022.
About FundedIQ's Axelyf Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Axelyf is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.